# CVE-2016-8355: Privilege escalation in Smiths-Medical CADD-Solis Medication Safety Software through 3.1

> Authenticated users can gain elevated SQL database privileges to modify drug libraries and user permissions in Smiths-Medical CADD-Solis software.

- **Severity:** Critical 9.9 (`CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H`)
- **Exploited in the wild:** Not known
- **Login needed:** Any signed-in user
- **Attackable:** Over the internet
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 13 Feb 2017
- **Updated:** 6 Aug 2024
- **Also known as:** GHSA-2h29-mg3v-85xj

## What is CVE-2016-8355?

CVE-2016-8355 is a critical vulnerability in Smiths-Medical CADD-Solis Medication Safety Software through 3.1, published on 13 Feb 2017. Any signed-in user can exploit it over the network, with no action from the victim.

### Official description

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.

Weakness: CWE-306 (Missing Authentication for Critical Functionality)

## Which versions are affected by CVE-2016-8355?

It affects 1 product.


Products: Smiths-Medical Cadd-Solis Medication Safety Software.

## How do I fix CVE-2016-8355?

No fix has been published for CVE-2016-8355 yet. Limit exposure of the affected software until one is available.

## Is CVE-2016-8355 being exploited?

There is no known exploitation of CVE-2016-8355 in the wild and no public exploit code.

## Other vulnerabilities in Smiths-Medical CADD-Solis Medication Safety Software through 3.1

- [CVE-2016-8358](https://insights.sbomify.com/CVE-2016-8358/): Security feature bypass in Smiths-Medical CADD-Solis Medication Safety Software through 3.1 (high 8.5)

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2016-8355 and fix it if it is affected.

What it is: CVE-2016-8355 is a critical vulnerability in Smiths-Medical CADD-Solis Medication Safety Software through 3.1, published on 13 Feb 2017. Any signed-in user can exploit it over the network, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2016-8355 in the wild and no public exploit code.

Affected product: Smiths-Medical CADD-Solis Medication Safety Software through 3.1. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2016-8355/ (Markdown: https://insights.sbomify.com/CVE-2016-8355/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2016-8355
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2016-8355
- OSV: https://osv.dev/vulnerability/CVE-2016-8355

---
From sbomify Insights: https://insights.sbomify.com/CVE-2016-8355/
Summaries are generated and may contain mistakes; the official description above is the record.